Read the latest news and development in generics and biosimilars research.

Subscribe now to GaBI Journal.

The scope of GaBI Journal, as one of the umbrella projects of GaBI, is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical  science and policy.  Materials published in GaBI Journal include high quality research reports, literature reviews and case studies, all of which are peer reviewed.

GaBI Journal publishes independent, high quality, authoritative and peer reviewed scientific articles concerning any aspects of the research into and development of cost-effective medicines, irrespective of their sources.

GaBI Journal publishes manuscripts  in  all  aspects  of  generic and biosimilar  medicines, including but not limited to the development of formulations, production, testing (including equivalence – in vivo and in vitro), model development, regulatory issues, supply chain management and pharmacoeconomics. Experts are highly motivated to share their knowledge and professional experiences through their contributing articles.